Article
Monoclonal antibodies recognize conformational epitopes on wild-type and recombinant mutant amidases from pseudomonas aeruginosa.
Molecular biotechnology - 1 Oct 2007
Martins Sónia, Lourenço Sara, Karmali Amin, Serralheiro Maria Luísa
Abstract excerpt
Hybridoma technology was used to raise monoclonal antibodies (MAbs) against wild-type amidase from Pseudomonas aeruginosa. Hybridoma clones secreting polyol-responsive MAbs (PR-MAbs) were screened that bind antigen tightly. but release under mild- and non-denaturing elution conditions, which can be used as ligands in immunoaffinity chromatography. Two of these hybridoma clones (C9E4 and B1E4) secreting MAbs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
